Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram

International Clinical Psychopharmacology

Volumn 13, Issue 5, 1998, Pages 205-211

  Ekselius, L ^a   Von Knorring, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Citalopram; Comorbidity; Major depressive disorder; Personality disorder; Sertraline; SSRI

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; AVOIDANCE BEHAVIOR; BORDERLINE STATE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPENDENT PERSONALITY DISORDER; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE REGRESSION; PARANOIA; PERSONALITY; PERSONALITY DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

EID: 0031713720     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199809000-00003     Document Type: Article

References (28)

1. Alnæs R, Torgersen S (1998): DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population. Acta Psychiatr Scand 78:348-355.
2. Ansseau M, Troisfontaines B, Papart P, von-Frenekell R (1991): Compulsive personality as predictor of response to sertonergic antidepressants. BMJ 303:760-761.
3. Black DW, Bell S, Hulbert J, Nasrallah A (1988): The importance of axis II in patients with major depression. J Affect Disord 14:115-122.
4. Casey PR, Tyrer P (1990): Personality disorder and psychiatric illness in general practice. Br J Psychiatry, 156:261-265.
5. Cornelius JR, Soloff PH, Perel JM, Ulrich RF (1991): A preliminary trial of fluoxetine in refractory borderline patients. J Clin Psychopharmacol 11:116-120.
6. Corruble E, Ginestet D, Guelfi JD (1996): Comorbidity of personality disorders and unipolar depression: a review. J Affect Disord 37:157-170.
7. Davidson J, Miller R, Strickland R (1985): Neuroticism and personality disorder in depression. J Affect Disord 8:177-182.
8. Ekselius L, Lindström E, von Knorring L, Bodlund O, Kullgren G (1994a): SCID II interviews and the SCID screen questionnaire as diagnostic tools for personality disorders in DSM-III-R. Acta Psychiatr Scand 90:120-123.
9. Ekselius L, Lindström E, von Knorring L, Bodlund O, Kullgren G (1994b): Comorbidity among the personality disorders in the DSM-III-R. Personality Indiv Diff 17:155-60.
10. Ekselius L, von Knorring L, Eberhard G (1997): A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychopharmacol 12:323-331.
11. Fava M, Bouffides E, Pava JA, McCarthy MK, Steingard RJ, Rosenbaum JF (1994): Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother Psychosomatics 62:160-167.
12. Fava M, Uebelacker LA, Alpert JE, Nirenberg AA, Pava JA, Rosenbaum JF (1997): Major depressive subtypes and treatment response. Biol Psychiatry 42:568-576.
13. Guy W (1976): Clinical global impressions. In: ECDEU Manual. NIMH Rockville, Maryland: US Dept of Health and Human Services: 1976. pp.217-222.
14. Kavoussi RJ, Liu J, Coccaro EF (1994): An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 55:137-141.
15. Loranger AW, Lenzenweger MF, Gartner AF, Susman VL, Herzig J, Zammit GK, et al. (1991): Trait-state artefacts and the diagnosis of personality disorders. Arch Gen Psychiatry 48:720-728.
16. Markovitz PJ, Calabrese JR, Schuz SC, Meltzer HY (1991): Fluoxetine in borderline and schizotypal personality disorder. Am J Psychiatry 148:1064-1067.
17. Montgomery S, Asberg M (1979): A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
18. Norden MJ (1989): Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 13:885-893.
19. Patience DA, McGuire RJ, Scott AIF, Freeman CPL (1995): The Edinburgh primary care depression study: personality disorder and outcome. Br J Psychiatry 167:324-330.
20. Pfohl B, Stangl D, Zimmerman M (1984): The implications of DSM-III disorders for patients with major depression. J Affect Disord 7:309-318.
21. Reich JH, Green AI (1991): Effect of personality disorders on outcome of treatment. J Nerv Ment Dis 179:74-82.
22. Reich JH, Vasile RG (1993): Effect of personality disorders on the treatment outcome of Axis I conditions: an update. J Nerv Ment Dis 181:475-484.
23. Sato T, Sakado K, Sato S, Morikawa T (1994): Cluster A personality disorder: a marker of worse treatment outcome of major depression? Psychiatry Res 53:153-159.
24. Salzman C, Wolfson AN, Saltzberg A, Looper J, Henke R, Albanese M, et al. (1995): Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 15:23-29.
25. Spitzer RL, Williams JBW, Gibbon M (1987): Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). New York, NY: New York State Psychiatric-Institute, Biometrics Research.
26. Zimmerman M (1994): Diagnosing personality disorders. Arch Gen Psychiatry 51:225-245.
27. Zimmerman M, Pfohl B, Coryell WH, Stangl D, Corenthal C (1988): Diagnosing personality disorder in depressed patients. Arch Gen Psychiatry 45:733-737.
28. Zimmerman M, Pfohl B, Coryell WH, Corenthal C, Stangl D (1991): Major depression and personality disorder. J Affect Disord 22:199-210.